New drug prophylaxis for M avium infection.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D009162:Mycobacterium avium; D011446:Prospective Studies; D017828:Rifabutin; D012294:Rifamycins / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy* / Q000209:etiology
D000995:Antitubercular Agents; D012294:Rifamycins; D017828:Rifabutin